In the media
- 28 January, 2019
“After the Smoke Clears” Community Charity Event in Southern California
Calabasas Behavioral Health hosts “After the Smoke Clears”, a free community event offering emotional and mental health to victims of the Woolsey Fire and Borderline Shooting in Southern
Read More 
18 December, 2018TMS Treatment for OCD Expands to Alaska
With three Achieve TMS locations in Alaska: Anchorage, Fairbanks, and Wasilla, patients now have the opportunity to receive treatment in America’s most northern state. NBC
Read More
12 December, 2018BrainsWay Among 8 Medical Products Selected by FDA to Combat the Opioid Crisis
The FDA is trying new strategies to fight the opioid crisis, and devices such as BrainsWay Deep TMS are one way to treat this ongoing social ill. BrainsWay has been selected as one of eight healthcare
Read More
11 December, 2018BrainsWay Running Clinical Trials to Treat Nicotine Addiction
An interview between renowned neurologist and psychiatrist, Dr. Nolan Williams, and a representative of Medgadget, highlights how BrainsWay has developed a TMS coil to treat nicotine addiction. Currently,
Read More
30 October, 2018BrainsWay Deep TMS Helping Veterans Suffering From Depression
Often times when a veterans returns home from war, post traumatic stress disorder (PTSD) is a very common result, which eventually leads to depression. One veteran who returned home suffering from PTSD
Read More
12 October, 2018Mass Live Shows That Medication Has Its Limits
BrainsWay’s Deep TMS device is effective at not only treating depression, but particularly those patients who have not responded to their medication and psychotherapy treatment. Most times, failed
Read More
8 October, 2018TMS Offers New Option to Counteract Suicide Rate
Depression affects 450 million people worldwide and 15 million adults in the U.S. alone, with suicide being the tenth leading cause of death in the United States, claiming over 40,000 lives every year.
Read More
28 September, 2018New U Therapy Expands Deep TMS to Santa Clarita
The results of TMS clinical trials report that 44% of treatment-resistant patients achieved a positive response after the full course of treatment. One-third of patients claimed remission from their
Read More
19 September, 2018BrainsWay’s TMS Device Cleared for OCD Treatment
The Food and Drug Administration has recently cleared Deep TMS treatment to treat those suffering from Obsession Compulsive Disorder (OCD), as an adjunct therapy to medication and psychotherapy. BrainsWay
Read More
12 September, 2018Dr. Oscar Morales Interviewed by Health Professional Radio
Dr. Oscar Morales, psychiatrist and Senior Medical Advisor at Achieve TMS East, is interviewed by Health Professional Radio on the use of BrainsWay Deep TMS for treatment of depression and OCD. The
Read More
5 September, 2018ADHD Patient Participates in TMS Clinical Trial
A young woman suffering from ADHD didn’t like the idea of medicating herself, so subsequently enrolled in a clinical trial for Deep TMS treatment. The procedure is meant to be an alternative to
Read More
29 August, 2018HPR Treatment Centers Expands Use of Deep TMS Throughout the US
HPR Treatment Centers, from its beginnings in Hackensack, NJ, has expanded from coast to coast, and is leveraging BrainsWay Deep TMS technology to treat its MDD patients. MyVeronaNJ profiles a new
Read More
25 June, 2018Jersey Matters Features MDD Patient Helped by Integrative Behavioral Care & BrainsWay
With only one out of every three patients using antidepressants achieve remission, its no secret why more and more patients suffering from depression seek TMS treatment. Jersey Matters interviews
Read More
9 April, 2018Health Care and Hospitals Opening Up to TMS
Not only have private practices been experiencing success with TMS, but hospitals have been as well according to Carlos Rueda, the MD chairman of psychiatry for St. Joseph’s Behavioral Health
Read More
13 December, 2016BrainsWay Raises Close to 9 Million to Treat Depression
After years of developing the device, BrainsWay has invested $8.5 million to strengthen the Brain disorder treatment business. Now, the company is set to launch its device consisting of a helmet lined
Read More